|
市場調查報告書
全球癌症治療藥市場:市場預測(至2013年)
The Oncology Market Forecast to 2013
|
全球癌症治療藥市場:市場預測(至2013年) 是由出版商Cutting Edge Information在2008年07月所出版的。
這份英文市場調查報告書包含400 Pages 價格從美金9995起跳。
本報告書內容包括:130種以上的癌症治療藥品牌資訊、銷售金額資料、認可的治療症狀、產品開發階段等各種資料、2013年之前的市場預測等。內容綱要摘記如下:
第1章 分類別癌症治療藥分析(130種以上的藥品介紹)
- 品牌資訊
- 銷售金額資料
- 許可治療症狀
- 目前的產品開發階段
- 競爭・策略性定位
- 市場機會・品牌的成長
- 專利・非專利藥品・訴訟相關資訊
第2章 治療癌症症狀
- 癌症種類別市場分析
- 銷售金額・主要藥物・重要企業
- 銷售預測・未來的藥物評價・參與企業
- 產品線藥狀況
- 主要事件・治療上的改變・專利到期
第3章 主要企業的癌症相關介紹
- 主要癌症相關企業分析
- 銷售金額・主要藥物・重要企業
- 銷售預測・未來的藥物評價・參與企業
- 產品線藥狀況
封面圖片:
Abstract
Give Your Team Access to the Most Comprehensive Oncology Forecast Ever
Created
Cutting Edge Information' s new report, "Oncology Market Forecast to 2013,"
explores the fiercely competitive oncology market in a way that no other
available forecast can match.
Our experienced analysts have reviewed thousands of historical and forecasted
data points to provide the most comprehensive oncology market outlook ever -
pulling together data from our own proprietary PharmaEdge databases, along
with hundreds of additional public and private databases worldwide.
Give your brand team all the oncology data it needs to make critical
product decisions!
Key Questions This Report Will Answer:
- Which drugs will make the most money in the next five years?
- Which drug classes are poised for exponential growth?
- Whose portfolio will allow them to jump out in front of the oncology
market?
Table of Contents
Chapter 1: Analysis of Cancer Drugs by Classes (130+ Drug Profiles)
- - BRAND INFORMATION
- Brand and generic name
- Drug class
- Delivery mechanism
- Line of treatment
- - SALES DATA
- Historical/current sales
- Forecasted sales
- - APPROVED INDICATIONS
- - CURRENT PRODUCT DEVELOPMENT PHASES
- - COMPETITIVE AND STRATEGIC POSITIONING
- - MARKET OPPORTUNITIES AND BRAND GROWTH
- - PATENT, GENERIC AND LITIGATION INFORMATION
Chapter 2: Oncology Indications
- - ANALYSIS OF MARKETS FOR DIFFERENT CANCER TYPES
- Current sales, major drugs and important companies
- Forecasted sales and assessment of future drugs and market players
- Pipeline development status
- Major market events, changes in treatments, patent expirations, etc.
Chapter 3: Top Companies' Oncology Portfolios
- - ANALYSIS OF MAJOR ONCOLOGY COMPANIES
- Current sales, major drugs and important companies
- Forecasted sales and assessment of future drugs and market players
- Pipeline development status
|